NEW YORK--(BUSINESS WIRE)--
The Board of Directors of Bristol-Myers
Squibb Company (NYSE:BMY) today declared a quarterly dividend of
thirty-nine cents ($0.39) per share on the $.10 par value Common Stock
of the corporation. The next quarterly dividend will be payable on
November 1, 2017, to stockholders of record at the close of business on
October 6, 2017.
The directors also declared a quarterly dividend of fifty cents ($0.50)
per share on the $2.00 Convertible Preferred Stock of the corporation,
payable December 1, 2017 to stockholders of record at the close of
business on November 7, 2017.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission
is to discover, develop and deliver innovative medicines that help
patients prevail over serious diseases. For more information about
Bristol-Myers Squibb, visit us at BMS.com
or follow us on LinkedIn,
Twitter,
and YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170913006455/en/
Source: Bristol-Myers Squibb Company